Quanta Inc - SIC # 2833 - MEDICINAL CHEMICALS AND BOTANICAL PRODUCTS

Ticker Exchange SIC # Website Latest Ticker
QNTA Over the counter 2833 http://www.quanta-inc.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Quanta Inc

Medolife Rx in Discussions with a Major Infomercial Agency and Receives Exceptionally Positive Product Reviews - Jun 1st, 2022 12:00 pm
Medolife Rx Schedules Conference Call with Investment Community to Discuss New Updates and Answer Questions - May 4th, 2022 12:00 pm
Medolife Rx Announces Changes to Management and Improvements to AELIA’s Marketing Efforts - Feb 7th, 2022 1:54 pm
Medolife Rx Submits Final Clinical Trial Data for Escozine Approval as a COVID-19 Treatment in The Dominican Republic - Jan 19th, 2022 1:00 pm
Medolife Rx Presents Its Venom-To-Drug Development Projects at an International Conference Held in the Dominican Republic - Jan 11th, 2022 1:00 pm
Medolife Rx Announces Results of Comparative Study of Its Flagship CBD-based Muscle Rub and Competitor Products - Dec 2nd, 2021 1:00 pm
Medolife Rx Schedules Conference Call with Investment Community To Discuss Third Quarter 2021 Financial and Operational Results and New Updates - Nov 19th, 2021 1:00 pm
Medolife Rx Announces Upcoming Release of New Aelia Commercials Featuring Tony Hawk - Nov 11th, 2021 1:30 pm
Medolife Rx Announces Uplisting to OTCQB Venture Market - Nov 3rd, 2021 12:00 pm
Medolife Rx Announces that the Government of the Dominican Republic is Willing to Include Escozine into its COVID-19 Treatment Regimen - Oct 14th, 2021 12:30 pm
Medolife Rx Reports 257% Increase in Efficacy of Ibuprofen Through Proprietary Polarization Method, Looks to Expand Into Other APIs - Oct 12th, 2021 12:30 pm
Medolife Rx Initiates Comparative Study of Its Flagship CBD-based Muscle Rub and Competitor - Oct 6th, 2021 12:30 pm
Medolife Rx Files Bi-Annual Report With Ministry of Environment in the Dominican Republic, Details Reservation Expansion and Exceeds Regulatory Expectations - Sep 29th, 2021 12:30 pm
Medolife Rx Launches Ad Campaign With Tony Hawk, Sees Immediate Positive Results - Sep 23rd, 2021 2:47 pm
Medolife Rx Clarifies April 13, 2021 Press Release - Sep 21st, 2021 10:09 pm
Medolife Rx Completes Bi-Annual Visit From Ministry of Environment to Scorpion Reservation, Receives Positive Feedback and Re-Affirmation of Joint Venture - Sep 15th, 2021 12:30 pm
Medolife Rx Recaps Successful Attendance at Tony Hawk Event; Saw Significant Product Exposure - Sep 1st, 2021 2:40 pm
Medolife Rx Reports Second Quarter 2021 Financial and Operational Results, Schedules Conference Call With Investment Community - Aug 23rd, 2021 9:15 pm
Medolife Rx to Participate in Inaugural Tony Hawk’s Vert Alert, Showcasing Breakthrough Pain Relief and Immunapen Product Lines - Aug 5th, 2021 11:00 am
Medolife Rx Launches Pharmacokinetic Study on Lead Drug Candidate as Next Step in Pre-IND FDA Submission - Aug 3rd, 2021 11:00 am